[Establishment of cholecystokinin specific radioimmunoassay-determination of CCK in human plasma]. 1983

K Tateishi, and T Hamaoka

UI MeSH Term Description Entries
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Tateishi, and T Hamaoka
May 1983, Digestive diseases and sciences,
K Tateishi, and T Hamaoka
May 1993, The Tohoku journal of experimental medicine,
K Tateishi, and T Hamaoka
March 1981, Clinica chimica acta; international journal of clinical chemistry,
K Tateishi, and T Hamaoka
July 1983, Clinica chimica acta; international journal of clinical chemistry,
K Tateishi, and T Hamaoka
August 1988, Clinical chemistry,
K Tateishi, and T Hamaoka
May 1978, Zeitschrift fur Gastroenterologie,
K Tateishi, and T Hamaoka
May 1986, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!